Summary and Conclusions
Primary hyperparathyroidism remains a controversial disease, in part because of continuing uncertainty about its effects on neuropsychiatric function and risk of vascular events. Several observational studies have now demonstrated low rates of morbid events in patients with untreated, mild PHPT. It is this author's opinion that patients with mild PHPT who do not have recognized complications of the disease (renal stones or osteopenia) may be managed expectantly, with annual biochemical review and less frequent bone density assessments, until more conclusive data are available on other putative associations. Osteopenic patients with PHPT can be effectively treated either with surgery or antiresorptive agents, although the presence of renal stones at diagnosis is a clear indication for surgical intervention. Studies of the effects of calcimimetic agents and new vitamin D analogs may increase the range and efficacy of therapies available for medical management of PHPT.
Similar content being viewed by others
References
Heath H, Hodgson SF, Kennedy MA, 1980 N Engl J Med 302:189–193.
Christensson T, Hellstrom K, Wengle B, Alveryd A, Wikland B. 1976 Acta Med Scand 200:131–137.
Mundy GR, Cove DH, Fisken R, 1980 Lancet 1:1317–1320.
Jorde R, Bonaa KH, Sundsfjord J, 2000 J Clin Epidemiol 53:1164–1169.
Stenstrom G, Heedman PA, 1974 Acta Med Scand 195:473–477.
Heath DA, 1989 Endocrinol Metab Clin North Am 18:631–646.
Wermers RA, Khosla S, Atkinson EJ, Hodgson SF, O'Fallon WM, Melton LJ, 1997 Ann Intern Med 126:433–440.
Lundgren E, Rastad J, Thrufjell E, Akerstrom G, Ljunghall S 1997 Surgery 121:287–294.
al Zahrani A, Levine MA, 1997 Lancet 349:1233–1238.
Toft AD, 2000, Lancet 355:1478–1479.
Grey AB, 1997 Baillieres Clin Endocrinol Metab 11:101–116.
Silverberg SJ, Shane E, Jacobs TP, Siris ES, Gartenberg F, Seldin D, et al, 1990 Am. J. Med 89:327–334.
Silverberg SJ, 2000 J Clin Endocrinol Metab 85:3513–3514.
Kleerekoper M, Bilezkian JP, 1994 Am J Med 96:99–100.
Grey AB, Evans MC, Stapleton JP, Reid IR, 1994 Ann Intern Med 121:745–749.
Bilezikian JP, 2000 Endocrinol Metab Clin North Am 29:465–478.
Sancho JJ, Rouco J, Riera R, Sitges-Serra A, 1992 World J Surg 16:732–735.
Anonymous. 1991 J Bone Miner Res 6(Suppl):S9–S13.
Silverberg SJ, Gartenberg F, Jacobs TP, Shane E, Siris E, Staron RB, et al, 1995 J Clin Endocrinol Metabol 80:729–734.
Jabbour N, Corvilain J, Fuss M, Kinnaert P, van Geertruyden J, 1991 Surgery 172:25–29.
Deaconson TF, Wilson SD, Lemann J. 1987 Surgery 102:910–913.
Silverberg SJ, Shane E, Jacobs TP, Siris E, Bilezikian JP, 1999 N Engl J Med 341:1249–1255.
Sosa JA, Powe NR, Levine MA, Udelsman R, Zeiger MA, 1998 J Clin Endocrinol Metab 83:2658–2665.
Sampson MJ, van't Hoff W, Bicknell EJ, 1987 Q J Med 65:1009–1014.
Rubinoff H, McCarthy N, Hiatt RA, 1983 J Chronic Dis 36:859–868.
Rao DS, Wilson RJ, Kleerekoper M, Parfitt AM, 1988 J Clin Endocrinol Metab 67:1294–1298.
Posen S, Clifton-Bligh P, Reeve TS, Wagstaffe C, Wilkinson M, 1985 Q J Med 54:241–251.
Eigelberger MS, Clark OH, 2000 Endocrinol Metab Clin North Am 29:479–502.
Palmer M, Adami HO, Bergstrom R, Jakobsson S, Akerstrom G, Ljunghall S, 1987 Lancet 1:59–62.
Wermers RA, Khosla S, Atkinson EJ, Grant CS, Hodgson SF, O'Fallon WM, et al. 1998 Am J Med 104:115–122.
Lafferty FW, 1981 Arch Intern Med 141:1761–1766.
Sangal AK, Kevwitch M, Rao DS, Rival J 1989 South Med J 82:1116–1118.
Grey A, Reld I, 1995 Ann Intern Med 123:732.
Hesp R, Tellez M, Davidson L, et al, 1987 Bone Miner 2:301–310.
Duan Y, De Luca V, Seeman E 1999 J Clin Endocrinol Metab 84:718–722.
Piovesan A, Molineri N, Casasso F, Enmolo I, Ugliengo G, Cesario F, et al, 1999, Clin Endocrinol 50:321–328.
Nilsson IL, Aberg J, Rastad J, Lind L 1999 Surgery 126:1049–1055.
Grey AB, Stapleton JP, Evans MC, Tatnell MA, Reid IR, 1996 Ann Intern Med 125:360–368.
Silverberg SJ, Gartenberg F, Jacobs TP, Shane E, Siris E, Staron RB, et al, 1995 J Clin Endocrinol Metab 80:723–728.
Parisien M, Silverberg SJ, Shane E, et al. 1990 J Clin Endocrinol Metab 70:930–938.
Khosla S, Melton LJ, 3rd, Wermers RA, Crowson CS, O'Fallon W, Riggs B, 1999 J Bone Miner Res 14:1700–1707.
Vestergaard P, Mollerup CL, Frokjaer VG, Christiansen P, Blichert-Toft M, Mosekilde L, 2000 Br Med J 321:598–602.
Eastell R, 1998 N Engl J Med 338:736–746.
Marcus R, Madvig P, Crim M, et al. 1984 Ann Intern Med 100:633–640.
Selby PL, Peacock M, 1986 N Engl J Med 314:1481–1485.
Gallagher JC, Nordin BEC, 1972 Lancet 1:503–507.
Guo CY, Thomas WE, al-Dehaimi AW, Assiri AM, Eastell R, 1996 J Clin Endocrinol Metab 81:3487–3491.
Orr-Walker BJ, Evans MC, Clearwater JM, Horne A, Grey AB, Reid IR, 2000 Arch Intern Med 160:2161–2166.
Block MA, Dailey GE, Muchmore DE, 1989 Surgery 106:1063–1069.
McDernott MT, Perloff JJ, Kidd GS, 1994 J Bone Miner Res 9:509–514.
Lufkin EG, Wahner HW, O'Fallon WM, et al, 1992 Ann Intern Med 117:1–9.
Grey AB, Cundy TF, Reid IR 1994 Clin Endocrinol 40:671–677.
Diamond T, Ng AT, Levy S, Magarey C, Smart R 1996 Osteoporosis Int 6:329–333.
Fuliehan GE, Moore F, Jr., LeBoff MS, Hurwitz S, Gundberg CM, Angell J, et al. 1999 J Clin Densitom 2:153–162.
O'Regan RM, Jordan VC, 2001 Semin Oncol 28:260–273.
Grey AB, Stapleton JP, Evans MC, Tatnell MA, Ames RW, Reid IR, 1995 Am J Med 99:636–641.
Ettinger B, Black DM, Mitlak BH, Knickerbocker RK, Nickelsen T, Genant HK, et al. 1999 JAMA 282:637–645.
Kristensen B, Mouridsen HT, Holmegaard SN, Transbol I, 1989 Cancer 64:1965–1967.
Zanchetta JR, Bogado CE, 2001 J Bone Miner Res 16:189–190.
Liberman UA, Weiss SR, Broll J, Minne HW, Quan H, Bell NH, et al. 1995 N Engl J Med 333:1437–1443.
McClung MR, Geusens P, Miller PD, Zippel H, Bensen WG, Roux C, et al. 2001, N Engl J Med 344:333–340.
Saag KG, Emkey R, Schnitzer TJ, Brown JP, Hawkins F, Goemaere S, et al. 1998 N Engl J Med 339:292–299.
Hosking D, Chilvers CE, Christiansen C, Ravn, P, Wasnich R, Ross, P et al. 1998 N Engl J Med 338:485–492.
Shane E, 1991 J Bone Miner Res 6:S131-S134.
Hamdy NA, Gray RE, McCloskey E, Galloway J, Rattenbury JM, Brown CB, et al. 1987 Bone 8:S69-S77.
Schmidli RS, Wilson I, Espiner EA, Richards AM, Donald RA, 1990 Clin Endocrinol 32:293–300.
Reasner CA, Stone MD, Hosking DJ, Ballah A, Mundy GR, 1993 J Clin Endocrinol Metab 77:1067–1071.
Rossini M, Gatti D, Isaia G, Sartori L, Braga V, Adami S, 2001 J Bone Miner Res 16:113–119.
Brown EM, Gamba, G, Riccardi D, Lombardi M, Butters R, Kifor O, et al, 1993 Nature 366:575–580.
Brown EM, 2000 Endocrinol Metab Clin North Am 29:503–522.
Brown EM, Pollak M, Hebert SC, 1998 Annu Rev Med 49:15–29.
Fox J, Lowe SH, Petty BA, et al. 1999 J Pharmacol Exp Ther 290:473–479.
Antonsen JE, Sherrard DJ, Andress, DL, 1998 Kidney Int 53:223–227.
Silverberg SJ, Bone HG, 3rd, Marriott TB, Locker FG, Thys-Jacobs S, Dziem G, et al. 1997 N Engl J Med 337:1506–1510.
Peacock M, Shoback DM, Greth WE, Binder TA, Graves T, Brenner RM, et al. 2001. J Bone Miner Res 16(Suppl 1):S163.
Collins MT, Skarulis MC, Bilezikian JP, Silverberg SJ, Spiegel AM, Marx SJ 1998 J Clin Endocrinol Metab 83:1083–1088.
Wada M, Nagano N, Furuya Y, Chin J, Nemeth EF, Fox J, 2000 Kidney Int 57:50–58.
Wada M, Furuya Y, Sakiyama J, Kobayashi N, Miyata S, Ishii H, et al. 1997 J Clin Invest 100:2977–2983.
Farnebo F, Enberg U, Grimelius L, Backdahl M, Schalling M, Larsson C, et al. 1997 J Clin Encorinol Metab 82:3481–3486.
Gogusev J, Duchambon P, Hory B, Giovannini M, Goureau Y, Sarfati E, et al. 1997 Kidney Int 51:328–336.
Holcik MF, 2001 Lancet 357:4–6.
Feldman E, 1999 Am J Med 107:637–639.
Clements MR, Davies M, Hayes ME, Hickey CD, Lumb GA, Mawer EB, et al. 1992 Clin Endocrinol 37:17–27.
Davies M, Hey SE, Selby PL, Berry JL, Mawer EB, 1997 J. Clin Endocrinol Metab 82:209–212.
Silverberg SJ, Shane E, Dempster DW, Bilezikian JP, 1999 Am J Med 107:561–567.
Rao DS, Honasoge M, Divine GW, Phillips ER, Lee MW, Ansari MR, et al. 2000. J Clin Endocrinol Metab 85:1054–1058.
Kantorowich V, Gacad MA, Seeger LL, Adams JS 2000 J Clin Endocrinol Metab 85:3541–3543.
El Abdaimi K, Papavasiliou V, Rabbani SA, Rhim JS, Goltzman D, Kremer R, 1999 Cancer Res 59:3325–3328.
Carling T, Rastad J, Szabo E, Westin G, Akerstrom G, 2000 J Clin Endocrinol Metab 85:2000–2003.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Grey, A. Primary hyperparathyroidism. Clinic Rev Bone Miner Metab 1, 35–42 (2002). https://doi.org/10.1385/BMM:1:1:35
Issue Date:
DOI: https://doi.org/10.1385/BMM:1:1:35